iC3b公司
单克隆抗体
脾脏
骨髓
葡聚糖
补体系统
补体受体
巨噬细胞-1抗原
启动(农业)
抗体调理
化学
药理学
分子生物学
癌症研究
生物
抗体
调理素
免疫学
生物化学
发芽
植物
作者
Feng Hong,Jun Yan,Jarek T Baran,Daniel J. Allendorf,Richard Hansen,Gary R. Ostroff,Pei‐Xiang Xing,Nai‐Kong V. Cheung,Gordon D. Ross
出处
期刊:Journal of Immunology
[American Association of Immunologists]
日期:2004-07-01
卷期号:173 (2): 797-806
被引量:534
标识
DOI:10.4049/jimmunol.173.2.797
摘要
Antitumor mAb bind to tumors and activate complement, coating tumors with iC3b. Intravenously administered yeast beta-1,3;1,6-glucan functions as an adjuvant for antitumor mAb by priming the inactivated C3b (iC3b) receptors (CR3; CD11b/CD18) of circulating granulocytes, enabling CR3 to trigger cytotoxicity of iC3b-coated tumors. Recent data indicated that barley beta-1,3;1,4-glucan given orally similarly potentiated the activity of antitumor mAb, leading to enhanced tumor regression and survival. This investigation showed that orally administered yeast beta-1,3;1,6-glucan functioned similarly to barley beta-1,3;1,4-glucan with antitumor mAb. With both oral beta-1,3-glucans, a requirement for iC3b on tumors and CR3 on granulocytes was confirmed by demonstrating therapeutic failures in mice deficient in C3 or CR3. Barley and yeast beta-1,3-glucan were labeled with fluorescein to track their oral uptake and processing in vivo. Orally administered beta-1,3-glucans were taken up by macrophages that transported them to spleen, lymph nodes, and bone marrow. Within the bone marrow, the macrophages degraded the large beta-1,3-glucans into smaller soluble beta-1,3-glucan fragments that were taken up by the CR3 of marginated granulocytes. These granulocytes with CR3-bound beta-1,3-glucan-fluorescein were shown to kill iC3b-opsonized tumor cells following their recruitment to a site of complement activation resembling a tumor coated with mAb.
科研通智能强力驱动
Strongly Powered by AbleSci AI